366 related articles for article (PubMed ID: 18195453)
1. Effects of GABAB receptor ligands in animal tests of depression and anxiety.
Frankowska M; Filip M; Przegaliński E
Pharmacol Rep; 2007; 59(6):645-55. PubMed ID: 18195453
[TBL] [Abstract][Full Text] [Related]
2. Effects of GABA(B) receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination.
Filip M; Frankowska M; Przegaliński E
Eur J Pharmacol; 2007 Nov; 574(2-3):148-57. PubMed ID: 17698060
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents.
Jacobson LH; Cryan JF
Neuropharmacology; 2008 Apr; 54(5):854-62. PubMed ID: 18328507
[TBL] [Abstract][Full Text] [Related]
4. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.
Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS
Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259
[TBL] [Abstract][Full Text] [Related]
5. Effects of GABAB receptor ligands in rodent tests of anxiety-like behavior.
Partyka A; Kłodzińska A; Szewczyk B; Wierońska JM; Chojnacka-Wójcik E; Librowski T; Filipek B; Nowak G; Pilc A
Pharmacol Rep; 2007; 59(6):757-62. PubMed ID: 18195467
[TBL] [Abstract][Full Text] [Related]
6. Effects of GABA(B) receptor agents on cocaine priming, discrete contextual cue and food induced relapses.
Filip M; Frankowska M
Eur J Pharmacol; 2007 Oct; 571(2-3):166-73. PubMed ID: 17610868
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the antianxiety and antidepressant activities of mosapride in Wistar albino rats.
Krishna V; Bairy KL; Patil N; Sunny SV
J Basic Clin Physiol Pharmacol; 2019 Jul; 30(4):. PubMed ID: 31318691
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant-like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents.
Nowak G; Partyka A; Pałucha A; Szewczyk B; Wierońska JM; Dybała M; Metz M; Librowski T; Froestl W; Papp M; Pilc A
Br J Pharmacol; 2006 Nov; 149(5):581-90. PubMed ID: 16921399
[TBL] [Abstract][Full Text] [Related]
9. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior.
Mombereau C; Kaupmann K; Froestl W; Sansig G; van der Putten H; Cryan JF
Neuropsychopharmacology; 2004 Jun; 29(6):1050-62. PubMed ID: 15039762
[TBL] [Abstract][Full Text] [Related]
10. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A; Stachowicz K; Tatarczyńska E
Neuropharmacology; 2006 Sep; 51(3):578-86. PubMed ID: 16828124
[TBL] [Abstract][Full Text] [Related]
11. Effects of imipramine or GABA(B) receptor ligands on the immobility, swimming and climbing in the forced swim test in rats following discontinuation of cocaine self-administration.
Frankowska M; Gołda A; Wydra K; Gruca P; Papp M; Filip M
Eur J Pharmacol; 2010 Feb; 627(1-3):142-9. PubMed ID: 19878670
[TBL] [Abstract][Full Text] [Related]
12. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A
Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
[TBL] [Abstract][Full Text] [Related]
13. Anxiolytic, antidepressant, and antistress activities of the aqueous extract of
Upadhyay G; Khoshla S; Kosuru R; Singh S
Indian J Pharmacol; 2016; 48(5):555-561. PubMed ID: 27721543
[TBL] [Abstract][Full Text] [Related]
14. The hemoglobin derived peptide LVV-hemorphin-7 evokes behavioral effects mediated by oxytocin receptors.
da Cruz KR; Turones LC; Camargo-Silva G; Gomes KP; Mendonça MM; Galdino P; Rodrigues-Silva C; Santos RAS; Costa EA; Ghedini PC; Ianzer D; Xavier CH
Neuropeptides; 2017 Dec; 66():59-68. PubMed ID: 28985964
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.
Griebel G; Simiand J; Serradeil-Le Gal C; Wagnon J; Pascal M; Scatton B; Maffrand JP; Soubrie P
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6370-5. PubMed ID: 11959912
[TBL] [Abstract][Full Text] [Related]
16. Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression.
Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
Behav Pharmacol; 2004 Dec; 15(8):523-34. PubMed ID: 15577451
[TBL] [Abstract][Full Text] [Related]
17. GABA(A) but not GABA(B) receptor stimulation induces antianxiety profile in rats.
Zarrindast M; Rostami P; Sadeghi-Hariri M
Pharmacol Biochem Behav; 2001; 69(1-2):9-15. PubMed ID: 11420063
[TBL] [Abstract][Full Text] [Related]
18. Effects of co-administration of the GABAB receptor agonist baclofen and a positive allosteric modulator of the GABAB receptor, CGP7930, on the development and expression of amphetamine-induced locomotor sensitization in rats.
Cedillo LN; Miranda F
Pharmacol Rep; 2013; 65(5):1132-43. PubMed ID: 24399709
[TBL] [Abstract][Full Text] [Related]
19. Positive allosteric modulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptors differentially modulates the behavioural effects of citalopram in mouse models of antidepressant and anxiolytic action.
Fitzpatrick CM; Larsen M; Madsen LH; Caballero-Puntiverio M; Pickering DS; Clausen RP; Andreasen JT
Behav Pharmacol; 2016 Sep; 27(6):549-55. PubMed ID: 27341500
[TBL] [Abstract][Full Text] [Related]
20. Harmane induces anxiolysis and antidepressant-like effects in rats.
Aricioglu F; Altunbas H
Ann N Y Acad Sci; 2003 Dec; 1009():196-201. PubMed ID: 15028588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
